23
Participants
Start Date
May 18, 2015
Primary Completion Date
August 1, 2018
Study Completion Date
August 1, 2018
Fenofibrate
Fenofibrate is a peroxisome proliferator-activated receptor alpha agonist that is demonstrated to reduce triglyceride concentrations in the blood.
No intervention
A cohort of participants will be randomized to receive no study drug, but will engage in study encounters.
James J. Peters VA Medical Center, Bronx, NY, The Bronx
Kessler Institute for Rehabilitation, West Orange
VA Office of Research and Development
FED